Cargando…
Chronic Anti-Coagulation Therapy Reduced Mortality In Patients With High Cardiovascular Risk Early In COVID-19 Pandemic
BACKGROUND: Coronavirus disease 2019 (COVID-19) is associated with provoked thrombo-inflammatory responses. Early in the COVID-19 pandemic this was thought to contribute to hypercoagulability and multi-organ system complications in infected patients. Limited studies have evaluated the impact of ther...
Autores principales: | Zaghloul, Mohamed S., Jammeh, Momodou, Gibson, Andrew, Luo, Suhong, Chadwick-Mansker, Kelley, Liu, Qianjin, Yan, Yan, Zayed, Mohamed A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681047/ https://www.ncbi.nlm.nih.gov/pubmed/36415466 http://dx.doi.org/10.21203/rs.3.rs-2252262/v2 |
Ejemplares similares
-
Chronic anti-coagulation therapy reduced mortality in patients with high cardiovascular risk early in COVID-19 pandemic
por: Zaghloul, Mohamed S., et al.
Publicado: (2023) -
Outpatient Chronic Anticoagulation Improves Outcomes in Patients With Coronavirus Disease 2019 and Cardiovascular Risk Factors
por: Gibson, Andrew K., et al.
Publicado: (2021) -
Modified bare-back micro-retrograde tibial arterial access to facilitate peripheral endovascular therapy
por: Gani, Faiz, et al.
Publicado: (2023) -
Reoperative Brachial Plexus Neurolysis After Previous Anatomically Complete Supraclavicular Decompression for Neurogenic Thoracic Outlet Syndrome: A 10-Year Single-Center Case Series
por: Jammeh, Momodou L., et al.
Publicado: (2022) -
Strain Specific Phage Treatment for Staphylococcus aureus Infection Is Influenced by Host Immunity and Site of Infection
por: Pincus, Nathan B., et al.
Publicado: (2015)